Mingfang Zhang
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Elucidating the mechanistic association of xylene inducing non-small cell lung cancer through network toxicology and molecular docking analysis.
Journal: PloS one
Published: October 09, 2025
Deciphering the Effects of the PYCR Family on Cell Function, Prognostic Value, Immune Infiltration in ccRCC and Pan-Cancer.
Journal: International journal of molecular sciences
Published: July 08, 2024
EPAS1 Promoter Hypermethylation is a Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer.
Journal: Genetic testing and molecular biomarkers
Published: August 03, 2022
PRKCDBP Methylation is a Potential and Promising Candidate Biomarker for Non-small Cell Lung Cancer.
PRKCDBP Methylation is a Potential and Promising Candidate Biomarker for Non-small Cell Lung Cancer.
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: February 28, 2022
An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma.
An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma.
Journal: Scientific reports
Published: January 16, 2022
LINC00662: A new oncogenic lncRNA with great potential.
Journal: Journal of cellular physiology
Published: July 13, 2021
Hypermethylation of tumor necrosis factor decoy receptor gene in non-small cell lung cancer.
Journal: Oncology letters
Published: April 28, 2019
AIM2 inflammasome mediates Arsenic-induced secretion of IL-1 β and IL-18.
Journal: Oncoimmunology
Published: October 02, 2015
Autophagy inhibition by sustained overproduction of IL6 contributes to arsenic carcinogenesis.
Journal: Cancer research
Published: May 17, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026